Mobile menu not yet fully implemented
Background stories of how others approached and experienced their European Horizon funding trajectory.
Published on | 3 years ago
Programmes ICTFounded in 1999, Luciad serves clients in Europe, Asia and the Americas. Though it recently was acquired by Hexagon Geospatial, they kept an agile SME mindset. Thousands of end users work directly with Luciad’s geospatial applications, and major systems integrators (think Airbus Defense and Space, Lufthansa Systems, NATO, Thales…) incorporate its software in their own products.
NCP Flanders went to Leuven to interview Frederic Houbie, the Research Projects Manager at Luciad, about how he sees Horizon 2020. Luciad is a partner in the MARISA project, which is a collaborative RIA project submitted to an ICT call topic.
Read the full article for details
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.